David Nassif Insider Profile
4 Followers
David Nassif, CFO / CLO at Pharvaris, holds 120.30K shares in Pharvaris (Ticker: PHVS), holds 45.24K shares in Sio Gene Therapies (Ticker: SIOX), holds 0.00 shares in Steadymed (Ticker: STDY). Most recently, David Nassif Sold ― shares of Pharvaris on May 26, 2026 for an estimated value of $303.00K.
David Nassif has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CFO / CLO
Roles that David Nassif holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David Nassif
David Nassif's Trading History
Pharvaris
May 26, 2026
CFO / CLO
Informative Sell
303.00K
$4.25M
Steadymed
Sep 04, 2018
―
Uninformative Sell
98.82K
$0.00
Sio Gene Therapies
Dec 09, 2021
―
Uninformative Buy
―
$21.63K
List of latest transactions for each holding click on a transaction to see David Nassif's performance on stock
You May Also Like
David Nassif insider profile FAQ
What is the percentage of profitable transactions made by David Nassif?
The percentage of profitable transactions made by David Nassif is ―.
What is the average return per transaction made by David Nassif?
The average return per transaction made by David Nassif is ―.
What stocks does David Nassif hold?
David Nassif holds: PHVS, STDY, SIOX stocks.
What was David Nassif’s latest transaction?
David Nassif latest transaction was an Informative Sell of $303.00K.
What was David Nassif's most profitable transaction?
David Nassif’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David Nassif's role in Pharvaris?
David Nassif's role in Pharvaris is CFO / CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.